Hohl Benjamin Insider Trades

Insider Trading History

Track insider trading activity for Hohl Benjamin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $2.48M 51,000 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$296k 10,000 shares
$29.58
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $7.29M 150,000 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.75M 175,000 shares
$27.16
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.75M 36,000 shares
Last Trade
Dec 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$233k 13,000 shares
$17.93
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $4.47M 92,056 shares
Last Trade
Dec 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$233k 13,000 shares
$17.93
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.11M 105,056 shares
Last Trade
Sep 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66k 3,250 shares
$20.30
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.12M 23,000 shares
Last Trade
Sep 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.3k 3,250 shares
$20.40
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.28M 26,250 shares
Last Trade
Sep 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66k 3,250 shares
$20.30
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.28M 26,250 shares
Last Trade
Aug 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.68
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.12M 23,000 shares
Last Trade
Aug 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67k 3,250 shares
$20.63
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.26M 108,306 shares
Last Trade
Aug 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.68
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.42M 111,556 shares
Last Trade
Jul 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.67
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.12M 23,065 shares
Last Trade
Jul 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.5k 3,250 shares
$20.47
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.28M 26,250 shares
Last Trade
Jul 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.67
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.12M 23,000 shares
Last Trade
Jul 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.7k 1,000 shares
$22.66
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.58M 114,806 shares
Last Trade
Jul 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.8k 1,000 shares
$22.78
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.17M 24,000 shares
Last Trade
Jul 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.8k 1,000 shares
$22.78
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.63M 115,806 shares
Last Trade
Jun 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.68
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.28M 26,250 shares
Last Trade
Jun 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 3,250 shares
$20.68
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $1.13M 23,198 shares
Last Trade
Jun 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$68k 3,250 shares
$20.91
$48.60
Enliven Therapeutics
Enliven Therapeutics ELVN
CHIEF FINANCIAL OFFICER
Holding Value $5.79M 119,056 shares
Last Trade
Jun 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.7k 3,000 shares
$21.91
$48.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up